Gwynedd Valley, PA, United States of America

Mark J Macielag

Average Co-Inventor Count = 5.0

ph-index = 11

Forward Citations = 553(Granted Patents)

Forward Citations (Not Self Cited) = 479(Sep 21, 2024)

DiyaCoin DiyaCoin 0.50 

Inventors with similar research interests:


Location History:

  • New Brunswick, NJ (US) (2004)
  • Raritan, NJ (US) (2007)
  • Branchburg, NJ (US) (1995 - 2014)
  • Cranbury, NJ (US) (2012 - 2014)
  • Spring House, PA (US) (2012 - 2017)
  • Gwynedd, PA (US) (2017)
  • Gwynedd Valley, PA (US) (2013 - 2023)
  • Lower Gwynedd, PA (US) (2014 - 2023)


Years Active: 1995-2025

where 'Filed Patents' based on already Granted Patents

90 patents (USPTO):
4 patents (CIPO):

Title: Mark J Macielag: Pioneering Innovations in Pharmaceutical Research

Introduction:

Mark J Macielag, a renowned inventor based in Gwynedd Valley, PA, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 88 patents. His innovative work focuses on developing solutions for thromboembolic disorders, inflammatory diseases, and neuropeptide Y receptor modulation.

Latest Patents:

Mark J Macielag's latest patents include groundbreaking inventions such as Pyridine N-oxide derivatives used as factor XIa inhibitors. These compounds have shown promise in treating thromboembolic disorders and inflammatory conditions by targeting plasma kallikrein activity. Additionally, his work on antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors opens up new possibilities for treating various diseases and disorders.

Career Highlights:

Mark J Macielag has honed his expertise through notable tenures at esteemed companies such as Janssen Pharmaceutica NV and Ortho-McNeil Pharmaceutical Corp. His leadership and innovative approach have been instrumental in driving forward cutting-edge research and development in the pharmaceutical industry, leading to numerous breakthroughs in drug discovery and treatment methodologies.

Collaborations:

Throughout his career, Mark J Macielag has collaborated with talented professionals in the field, including esteemed colleagues such as Yue-Mei Zhang and Bin Zhu. These collaborations have not only enriched his work but have also fostered a culture of innovation and collaboration that has propelled the advancement of pharmaceutical research.

Conclusion:

In conclusion, Mark J Macielag stands as a beacon of innovation in the pharmaceutical industry, with a rich tapestry of patents and inventions that have the potential to revolutionize healthcare. His dedication to pushing boundaries and seeking novel solutions underscores his commitment to making a lasting impact on the world of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…